SUMEDHA PHARMA LIMITED Financials
- Company number
- 11781923CopyCopy
- Registered office
- 209a Sheffield Road, Killamarsh, Sheffield S21 1DX
- Incorporated
- 22/01/2019
Company snapshot
- Status
- Active
- Employees
- 7 (2025)
- Latest financial data
- 2025
- Accounts type
- Unaudited abridged
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
26.36%vs 20242024: £82.68K
Total Assets
-3.84%vs 20242024: £598.82K
Cash in Bank
9.69%vs 20242024: £49.36K
Total Liabilities
-42.28%vs 20242024: £432.20K
Employees
0vs 20242024: 7
In 2025, SUMEDHA PHARMA LIMITED reported net assets of £104.46K. The same filing shows total assets of £575.83K, cash in bank of £54.14K and total liabilities of £249.47K. Reported headcount was 7 in 2025. Total Liabilities fell from £432.20K in 2024 to £249.47K in 2025 (-42.28%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
26.36%from £82.68K in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures SUMEDHA PHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
Increasedvs 2023Cash in Bank
+2.7%vs 2023+1.4% a year compound (CAGR)
Total Assets
-23.3%vs 2023-12.4% a year compound (CAGR)
Total Liabilities
-68.7%vs 2023-44% a year compound (CAGR)
Employees
0%vs 2023Biggest increase
Cash in Bank+2.7%
£52.70K in 2023 to £54.14K in 2025
Biggest decrease
Total Liabilities-68.7%
£796.84K in 2023 to £249.47K in 2025
SUMEDHA PHARMA LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in cash in bank, pointing to a more liquid cash position, set against a fall in total liabilities, pointing to lighter outstanding obligations. See the full year-by-year figures.
Ratios from the filed figures
Calculated from SUMEDHA PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 18.14%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 43.32%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 21.70%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 9.40%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for SUMEDHA PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 510.00 | 3.12K | -45.80K | 82.68K | 104.46K |
| Total Assets£ | 334.89K | 332.82K | 751.04K | 598.82K | 575.83K |
| Cash in Bank£ | 4.92K | 68.54K | 52.70K | 49.36K | 54.14K |
| Total Liabilities£ | 780.88K | 752.70K | 796.84K | 432.20K | 249.47K |
| Employees | 7 | 7 | 7 | 7 | 7 |
SUMEDHA PHARMA LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for SUMEDHA PHARMA LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
SUMEDHA PHARMA LIMITED reported net assets of £104.46K for 2025. That compares with £82.68K in 2024, a change of 26.36%.
SUMEDHA PHARMA LIMITED reported total assets of £575.83K for 2025. That compares with £598.82K in 2024, a change of -3.84%.
SUMEDHA PHARMA LIMITED reported cash in bank of £54.14K for 2025. That compares with £49.36K in 2024, a change of 9.69%.
SUMEDHA PHARMA LIMITED reported 7 employees in 2025, compared with 7 in 2024.
Between 2023 and 2025, SUMEDHA PHARMA LIMITED's cash in bank rose by 2.7%, total assets fell by 23.3%, total liabilities fell by 68.7% and employee numbers was unchanged. Cash in bank compounded at 1.4% a year across the two years to 2025, from £52.70K to £54.14K. Reported headcount went from 7 in 2023 to 7 in 2025.
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.